Fady Ibraham Malik, EVP Research & Development at CYTOKINETICS INC (CYTK), sold 12,033 shares at $62.15 ($748K) on 2026-03-17, disclosed to the SEC on 2026-03-18.
Seasonal sale ($748k) by EVP Research & Development — this insider has traded CYTK in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.15 | 4,397 | $273K | 36.5% |
| 2 | $62.15 | 7,636 | $475K | 63.5% |
| Total | $62.15 avg | 12,033 | $748K | 100% |
| Filing → |
| CYTK | SELL | 2026-09-08 | $264K | — | Filing → |
| CYTK | SELL | 2026-08-18 | $265K | — | Filing → |
| CYTK | SELL | 2026-07-23 | $282K | — | Filing → |